XM does not provide services to residents of the United States of America.
B
B

BerkeleyGroup

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK housebuilders bemoan lack of new election housing pledges

UK housebuilders bemoan lack of new election housing pledges By Aby Jose Koilparambil June 13 (Reuters) - Britain's housebuilders are disappointed with what they see as a lack of radical measures to tackle the country's housing shortage in the election manifestoes of both major parties, industry executives said on Thursday. At its manifesto launch, the Labour Party confirmed its plans to build 1.5 million new homes, just short of the 1.6 million homes over the next five years promised to voters
B
B
B
C
P
R
R
T

UK Conservatives promise to build 1.6 million homes in 5 years

UPDATE 1-UK Conservatives promise to build 1.6 million homes in 5 years Adds detail on timing, stamp duty SILVERSTONE, England, June 11 (Reuters) - Britain's governing Conservatives on Tuesday promised voters they would build 1.6 million h omes over the next five years if they are re-elected on July 4. Speaking after publishing his party's election manifesto setting out its future policies, Prime Minister Rishi Sunak said more homes would be built by speeding up planning approvals and "scrapping
B
P

UK's Conservatives promise to build 1.6 million homes

UK's Conservatives promise to build 1.6 million homes SILVERSTONE, England, June 11 (Reuters) - Britain's governing Conservatives promised voters they would build 1.6 million "well-designed" homes, as they outlined their future policies in a manifesto document on Tuesday ahead of an election on July 4. Reporting by Elizabeth Piper and Alistair Smou
B
P

UK homebuilders gain as cooling labour market boosts rate cut hopes

BUZZ-UK homebuilders gain as cooling labour market boosts rate cut hopes ** Shares of UK housebuilders .FTNMX402020 rise 1.3% after Britain's labour market showed more signs of cooling in April as the unemployment rate rose ** Official data showed the jobless rate for the three months to April rose to 4.4% from 4.3% between January and March, the h
B
B
B
C
H
P
R
T
U

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.